GLP3-RT is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.

It is a new entrant into the rapidly-expanding space of anti-obesity peptides. It is known as a GGG tri-agonist. This means that it works at all of the incretin receptors including GLP-1 and GIP as well as the glucagon receptor itself. Research indicates that it may be the most effective weight loss peptide yet developed, with some studies showing a rapid and sustained weight loss response as high as 24% of total body weight[1]. It is thought to promote weight loss by increasing energy expenditure as well as decreasing energy consumption. It does the former via action at the glucagon receptor and the latter through both central and peripheral appetite control.

PRODUCT DISCLAIMER:

Please note that lyophilized powder may break loose during shipping; this is a normal occurrence and does not affect the quality of the research product. Please note that quantities may vary between batches. Refer to the Certificate of Analysis for specific details.

Product Usage:

All products made available on this website are intended exclusively for research and development purposes and are strictly not for human consumption or therapeutic use. These products are not approved by the U.S. Food and Drug Administration (FDA), and no statements on this website have been evaluated by the FDA. The products and any information provided are not intended to diagnose, treat, cure, or prevent any disease or medical condition.